Hypothermia for Increased Intracranial Pressure: Is It Dead?

Area of Science:

• Neurosurgery
• Critical Care Medicine
• Neurotrauma

Background:

• Therapeutic hypothermia (HT) is a strategy to manage intracranial hypertension (ICH) in traumatic brain injury (TBI).
• Proposed mechanisms include reduced cerebral metabolic demand, improved oxygen delivery, and decreased cerebral blood volume to lower ICP.
• HT is complex, labor-intensive, and associated with adverse effects, with conflicting evidence from randomized controlled trials.

Purpose of the Study:

• To critically evaluate the role of controlling intracranial pressure (ICP) in TBI management.
• To assess the effectiveness of therapeutic hypothermia (HT) in reducing ICP.
• To determine the benefit-risk ratio of using HT in TBI patients.

Main Methods:

• Review of existing literature and clinical trial data on therapeutic hypothermia for TBI.
• Analysis of the physiological effects of HT on cerebral metabolism and hemodynamics.
• Evaluation of the clinical outcomes and adverse events associated with HT.

Main Results:

• Randomized controlled trials suggest HT may have no beneficial effect or could be harmful in TBI.
• The clinical utility of HT in reducing ICP is questionable.
• Significant adverse effects and procedural complexity challenge the widespread use of HT.

Conclusions:

• Therapeutic hypothermia should not be used as an early intervention for TBI outside of clinical trials.
• HT may still have a potential role in managing refractory intracranial hypertension in select TBI patients.
• Further research is needed to clarify the precise role and optimal application of HT in TBI.